BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12629518)

  • 1. Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2.
    Yamasaki S; Nishida K; Yoshida Y; Itoh M; Hibi M; Hirano T
    Oncogene; 2003 Mar; 22(10):1546-56. PubMed ID: 12629518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for Grb2-associated binder-1 in growth hormone signaling.
    Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
    Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation.
    Holgado-Madruga M; Wong AJ
    Cancer Res; 2004 Mar; 64(6):2007-15. PubMed ID: 15026337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous suppression of Erk and Akt/PKB activation by a Gab1 pleckstrin homology (PH) domain decoy.
    Ren Y; Wu J
    Anticancer Res; 2003; 23(4):3231-6. PubMed ID: 12926057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects.
    Jackson JG; St Clair P; Sliwkowski MX; Brattain MG
    Cancer Res; 2004 Apr; 64(7):2601-9. PubMed ID: 15059917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the mitogen-activated protein kinase signaling pathway by SHP2.
    Cunnick JM; Meng S; Ren Y; Desponts C; Wang HG; Djeu JY; Wu J
    J Biol Chem; 2002 Mar; 277(11):9498-504. PubMed ID: 11779868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes.
    Aasrum M; Ødegård J; Sandnes D; Christoffersen T
    Biochim Biophys Acta; 2013 Dec; 1833(12):3286-3294. PubMed ID: 24126105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
    Wu CJ; Qian X; O'Rourke DM
    DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gab1 signaling is regulated by EGF receptor sorting in early endosomes.
    Kostenko O; Tsacoumangos A; Crooks D; Kil SJ; Carlin C
    Oncogene; 2006 Oct; 25(50):6604-17. PubMed ID: 16715136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
    Habib AA; Chun SJ; Neel BG; Vartanian T
    Mol Cancer Res; 2003 Jan; 1(3):219-33. PubMed ID: 12556561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
    Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
    Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of epidermal growth factor receptor- Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression.
    Kameda H; Risinger JI; Han BB; Baek SJ; Barrett JC; Glasgow WC; Eling TE
    Cell Growth Differ; 2001 Jun; 12(6):307-18. PubMed ID: 11432805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
    Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
    Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid.
    Yart A; Roche S; Wetzker R; Laffargue M; Tonks N; Mayeux P; Chap H; Raynal P
    J Biol Chem; 2002 Jun; 277(24):21167-78. PubMed ID: 11916960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired substrate preference for GAB1 protein bestows transforming activity to ERBB2 kinase lung cancer mutants.
    Fan YX; Wong L; Marino MP; Ou W; Shen Y; Wu WJ; Wong KK; Reiser J; Johnson GR
    J Biol Chem; 2013 Jun; 288(23):16895-16904. PubMed ID: 23612964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.
    Saito T; Okada S; Ohshima K; Yamada E; Sato M; Uehara Y; Shimizu H; Pessin JE; Mori M
    Endocrinology; 2004 Sep; 145(9):4232-43. PubMed ID: 15192046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Grb2-associated docking protein in EGF- and insulin-receptor signalling.
    Holgado-Madruga M; Emlet DR; Moscatello DK; Godwin AK; Wong AJ
    Nature; 1996 Feb; 379(6565):560-4. PubMed ID: 8596638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.